c.grimaldi
TL2 · Osaka
Contributes reviews on supplier material. Based in Osaka.
Joined 10 October 2024 · last posted 3d
87 posts, newest first. Showing up to 150.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #88 · Practice › Interactions · 25 Jul 2026 · 0 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #113 · Evidence › Journal club · 25 Jul 2026 · 0 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. That matches what I was told, which is not the same…
-
Talking to a therapist about this specifically Replied, post #24 · Wellbeing › Mental health · 24 Jul 2026 · 0 likes Expectations set by other people's reported trajectories are a documented source of distress, and the trajectories posted are not representative. That holds for the…
-
What a certificate commits its issuer to Replied, post #70 · Analytics › COA interpretation · 21 Jul 2026 · 12 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #105 · Compounds › Semaglutide · 20 Jul 2026 · 0 likes Trying to state the molecular mass of semaglutide position in a way that someone who disagrees would recognise as fair, because I do not think the version in this…
-
Retatrutide mass and identity: what a report should show Replied, post #19 · Compounds › Retatrutide · 16 Jul 2026 · 8 likes Post #17 and I disagree about the size of the effect, not about the direction. Where I would push back on the retatrutide mass and identity consensus is the confidence,…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #57 · Evidence › Journal club · 13 Jul 2026 · 20 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #12 · Clinical › Prescriber conversations · 6 Jul 2026 · 27 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. I keep a log of this specifically because memory is…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #67 · Sourcing › Independent verification · 5 Jul 2026 · 0 likes Adding the measurement that post #64 says would settle it. A supplier that supplies a supplementary certificate for a lot released a year ago has demonstrated that its…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #42 · Outcomes › Body composition · 4 Jul 2026 · 0 likes A request rather than an answer: could whoever has the primary source for ultrasound and skinfolds post it? I have seen the claim three times this month and each…
-
What to include when your question involves a chromatogram — one year on Replied, post #50 · Start Here › How to Ask · 24 Jun 2026 · 0 likes Everything in post #48 holds. The case it does not cover is the one I have. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #68 · Sourcing › Red flags · 23 Jun 2026 · 5 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
-
Publication patterns in the BPC-157 literature, examined Replied, post #19 · Compounds › Repair & healing peptides · 22 Jun 2026 · 3 likes Adding what did not work for me on publication patterns, since the failures never get written up and they are half the useful information.
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #64 · Pharmacology › Pharmacokinetics · 4 Jun 2026 · 0 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #44 · Practice › Dosing & titration · 2 Jun 2026 · 15 likes On Micro-titration the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Tracking a shortage from primary sources rather than rumour Replied, post #23 · Access › Shortages · 26 May 2026 · 7 likes Genuine question rather than a rhetorical one: has anyone here actually observed tracking a shortage, as opposed to read about it? The thread is long and I cannot tell.
-
Does dual agonism explain the effect size, or is it dose? Started this topic · Compounds › Tirzepatide · 24 May 2026 · 26 likes Does dual agonism explain the effect size, or is it dose? I have a specific reason for asking rather than idle curiosity, and the context is below. A question about…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #2 · Access › Pricing · 24 May 2026 · 0 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Where the comparing prices across jurisdictions discussion usually stalls…
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #8 · Compounds › Secretagogues & GH axis · 17 May 2026 · 6 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #47 · Compounds › Repair & healing peptides · 3 May 2026 · 29 likes On Stability of BPC-157: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any…
-
The anatomy of a question that gets answered within an hour Replied, post #33 · Start Here › How to Ask · 1 May 2026 · 24 likes Confirming post #30 from a second method, which matters more than confirming it from a second person. A photograph of a vial is rarely useful and a photograph of a…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #63 · Research Methods › N-of-1 designs · 1 May 2026 · 0 likes Reporting the whole series rather than the interesting segment is the discipline that makes personal data worth reading. Selective reporting is the default without…
-
The best-written scientific paper you have read Replied, post #21 · Lounge › Off topic · 27 Apr 2026 · 15 likes One more thing on best-written scientific paper that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #85 · Clinical › Comorbidities · 27 Apr 2026 · 15 likes Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist.
-
A site rotation scheme that is easy enough to actually follow Replied, post #41 · Practice › Administration · 15 Apr 2026 · 1 like This follows post #39 rather than contradicting it. Site rotation scheme has been discussed here with more heat than it deserves, mostly because two definitions have…
-
Personal import allowances, compared — a second dataset Replied, post #104 · Access › International · 15 Apr 2026 · 0 likes Answering the question post #100 raises rather than the one it answers. The useful distinction on Personal import allowances is between what was measured and what was…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #66 · Clinical › Comorbidities · 13 Apr 2026 · 1 like I read post #64 twice before replying, because I had assumed the opposite. Type 2 diabetes is worth one more sentence than it usually gets, and the sentence is the one…
-
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #3 · Practice › Side effects · 11 Apr 2026 · 3 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Follow-up: State-level differences that actually matter Replied, post #24 · Regional › North America · 5 Apr 2026 · 20 likes The practical version of State-level differences is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #92 · Pharmacology › Pharmacokinetics · 3 Apr 2026 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Labelling requirements for research chemicals Replied, post #2 · Sourcing › Regulatory · 27 Mar 2026 · 20 likes This follows the opening post rather than contradicting it. I changed my mind about labelling requirements for research chemicals after someone here asked me for the…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #55 · Compounds › Tirzepatide · 23 Mar 2026 · 0 likes Taking post #54 at face value and following it one step further. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction —…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #99 · Meta › Site feedback · 14 Mar 2026 · 0 likes Confirming post #98 from a second method, which matters more than confirming it from a second person. Checked the topic list claim against the primary source this…
-
Contributing data without breaching anyone's privacy Replied, post #11 · Data & Tools › Datasets · 3 Mar 2026 · 5 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
Measurement error in a self-reported exposure Replied, post #48 · Evidence › Study critique · 24 Feb 2026 · 18 likes I read post #46 twice before replying, because I had assumed the opposite. Careful with the language on measurement error. "Not detected" and "not present" are…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #92 · Access › International · 5 Feb 2026 · 0 likes Narrowing post #89, because the general version has more than one answer. Country-by-country legality: compound approval and legal status differ substantially by…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #71 · Access › International · 24 Jan 2026 · 28 likes I had written a reply contradicting post #67 and deleted it. Here is what survived. What I would tell a new member reading about Language barriers in accessing for the…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #65 · Practice › Side effects · 19 Jan 2026 · 2 likes Post #61 and I disagree about the size of the effect, not about the direction. The published rates come from populations that were titrated on a defined schedule with…
-
Heterogeneity as information rather than as a nuisance Replied, post #42 · Evidence › Meta-analyses · 29 Dec 2025 · 3 likes Individual participant data pooling is a much stronger design than aggregate pooling and is rare because it requires cooperation rather than a search. I am confident…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #26 · Evidence › Trials · 20 Dec 2025 · 0 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
The decimal-point error, and the habit that catches it Replied, post #118 · Practice › Reconstitution · 18 Dec 2025 · 23 likes Decimal-point error is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Aggregates and why a purity assay may miss them entirely Replied, post #15 · Analytics › Impurities & related substances · 18 Dec 2025 · 16 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #6 · Data & Tools › Datasets · 17 Dec 2025 · 16 likes Where a value is derived rather than measured, mark it. Derived columns get treated as observations the moment the file leaves your hands. It is the sort of thing that…
-
Pen dose counters: what a click does and does not guarantee Replied, post #49 · Devices › Pens & autoinjectors · 15 Nov 2025 · 21 likes Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track using the dose counter is important if visibility is limited.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #3 · Clinical › Bloodwork · 29 Oct 2025 · 8 likes Two sentences on panel and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred from…
-
Follow-up: Why appetite effects are mostly central Replied, post #76 · Pharmacology › Receptor biology · 24 Oct 2025 · 0 likes Post #74 is right about the mechanism and I think understates the practical bit. Two things can be true about appetite effects at once: the mechanism is plausible and…
-
New subcategory: rationale and scope Replied, post #89 · Meta › Announcements · 22 Oct 2025 · 28 likes The arithmetic in post #86 is right; the assumption feeding it is the part to check. The edit is clearer. For anyone arriving now, read the edited version — the…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #4 · Data & Tools › Calculators · 20 Oct 2025 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Precision and significant figures: the calculators do not round to match your input…
-
Comparing two chromatograms from different laboratories, properly Replied, post #13 · Analytics › HPLC & UHPLC · 22 Sep 2025 · 27 likes I read post #11 twice before replying, because I had assumed the opposite. Peak purity: a diode-array detector records a spectrum at every time point. If a peak…
-
When a preprint is the best available evidence and we say so Replied, post #121 · Evidence › Preprints · 31 Aug 2025 · 13 likes Post #119 put the caveat in the right place and I want to underline it. Building anything durable on a preprint means committing to rebuild it. That is a reasonable…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #114 · Compounds › Secretagogues & GH axis · 30 Aug 2025 · 7 likes Right, and stated more narrowly than I would have dared to state it.
-
Criticising the method without criticising the authors — one year on Replied, post #20 · Evidence › Study critique · 29 Aug 2025 · 16 likes Adding a small correction to the Criticising the method without criticising summary above rather than a disagreement with it. The substance holds; one of the figures is…
-
What pooling buys you and what it destroys Replied, post #10 · Evidence › Meta-analyses · 25 Aug 2025 · 0 likes Worth separating pooling buys as a question about the compound from pooling buys as a question about the documentation. They get answered by different people and only…
-
High-resolution MS on aggregates and what it can see Replied, post #46 · Analytics › Mass spectrometry · 17 Aug 2025 · 23 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Substitution between formats during a shortage Replied, post #40 · Access › Shortages · 17 Aug 2025 · 7 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
History of disordered eating and why it changes the conversation Replied, post #7 · Clinical › Special populations · 3 Aug 2025 · 9 likes Adding a reference point for history of disordered eating. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #19 · Analytics › COA interpretation · 4 Jul 2025 · 0 likes Everything in post #17 holds. The case it does not cover is the one I have. When method identifiers are missing: "reversed-phase HPLC" is less specific than…
-
Realistic expectations for strength while losing weight quickly Replied, post #5 · Nutrition & Training › Resistance training · 30 Jun 2025 · 0 likes Confirming post #4 from a second method, which matters more than confirming it from a second person. An honest declaration on realistic expectations for strength: I…
-
Repeatability versus intermediate precision Replied, post #84 · Analytics › Method validation · 28 Jun 2025 · 24 likes That is clearer than the version I had in my head. Thank you.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #117 · Data & Tools › Calculators · 6 Jun 2025 · 10 likes On Validating a calculator against hand, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #111 · Practice › Interactions · 2 Jun 2025 · 3 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Follow-up: Documentation that appears only after payment Replied, post #85 · Sourcing › Red flags · 17 May 2025 · 5 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #40 · Sourcing › Independent verification · 16 May 2025 · 4 likes The version of splitting a vial that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and…
-
Reading an MS report that only gives you a single number Replied, post #80 · Analytics › Mass spectrometry · 16 May 2025 · 9 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Coming back to: An 18-month record including the parts that went badly Replied, post #48 · Outcomes › Progress reports · 5 May 2025 · 3 likes Everything in post #46 holds. The case it does not cover is the one I have. Menstrual cycle: for people who menstruate, weight can shift by several pounds across the…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #32 · Practice › Storage & stability · 1 May 2025 · 29 likes Door storage in a refrigerator is the warmest and most variable position in the appliance. A shelf at the back is a materially different environment. I would want a…
-
Storing a pen in use versus a pen unopened Replied, post #9 · Devices › Pens & autoinjectors · 21 Apr 2025 · 25 likes I read post #5 twice before replying, because I had assumed the opposite. A pen that will not dial to the intended dose is usually telling you the cartridge does not…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #21 · Sourcing › Vendor reports · 14 Apr 2025 · 1 like Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #127 · Compounds › Semaglutide · 1 Apr 2025 · 0 likes Where I part company with post #125, and it is a narrow parting. Worth separating published dose-response for semaglutide as a question about the compound from…
-
A ten-fold dose error caught before injection Replied, post #15 · Devices › Syringes & needles · 31 Mar 2025 · 28 likes Post #13 answers the question as asked. The question underneath it is different. Sharps containers are a legal requirement for disposal in several jurisdictions and a…
-
Mood changes: monitoring, and when to involve a professional Started this topic · Wellbeing › Mental health · 30 Mar 2025 · 60 likes Mood changes: monitoring, and when to involve a professional — setting out what I have, and where I think it stops being reliable. Mood changes — I have the observation…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #48 · Access › Pricing · 29 Mar 2025 · 11 likes Nothing here is financial advice and none of it is a route to a transaction.
-
Retatrutide dose escalation in the published trials Replied, post #42 · Compounds › Retatrutide · 23 Mar 2025 · 0 likes Comparisons with tirzepatide are being made across trials rather than within one. Different populations, different durations, different endpoints; the effect sizes are…
-
A request that was declined, and the reasoning Replied, post #3 · Documentation › Wiki requests · 26 Feb 2025 · 0 likes Requests for a document covering something the evidence does not support get declined, and the decline usually points at what could be written instead.
-
Identical chromatograms across two different lots Replied, post #83 · Sourcing › Red flags · 29 Jan 2025 · 3 likes I read post #79 twice before replying, because I had assumed the opposite. Inability to trace lots: if you ask "where was this synthesised, by whom, under what…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #43 · Analytics › COA interpretation · 23 Jan 2025 · 0 likes Where two documents for the same lot disagree, the useful question is which was measured and which was transcribed. Most such disagreements are the second. That is the…
-
Canadian access and provincial variation Replied, post #6 · Regional › North America · 20 Jan 2025 · 13 likes Say which country and which state or province. Regulatory position, availability and practical route can all differ within the same continent and frequently do. I would…
-
Escalating every six weeks instead of four: what I observed over eight months Replied, post #7 · Practice › Dosing & titration · 4 Jan 2025 · 10 likes The question underneath escalating every six weeks instead is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write…
-
Washout with a one-week half-life: the arithmetic Replied, post #63 · Research Methods › N-of-1 designs · 4 Dec 2024 · 11 likes Washout sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #126 · Compounds › Repair & healing peptides · 23 Nov 2024 · 2 likes Adding the measurement that post #125 says would settle it. What I would tell a new member reading about reading a preclinical wound-healing model for the first time:…
-
Reading a supplementary appendix and finding the interesting part Replied, post #21 · Evidence › Trials · 10 Nov 2024 · 0 likes Worth separating two things that post #19 runs together. Adding a reference point for reading a supplementary appendix. Mine is a single case, collected without…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #24 · Meta › Wiki maintenance · 2 Nov 2024 · 23 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for. I am not the right person to answer the follow-up to this.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #70 · Nutrition & Training › Hydration & electrolytes · 1 Sep 2024 · 8 likes Post #69 is the version of this I will quote in future. One addition. Very low total intake produces multiple simultaneous deficiencies rather than one, which is why…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #36 · Clinical › Prescriber conversations · 12 Aug 2024 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #5 · marked as the solution · Analytics › Method validation · 21 Jul 2024 · 10 likes Worth separating two things that the opening post runs together. Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance.…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #24 · Practice › Dosing & titration · 7 Jul 2024 · 0 likes Where I part company with post #20, and it is a narrow parting. Reaching a dose and staying there for a year: the question of whether a stable dose remains effective…
-
Assessing a warm arrival: the decision process — one year on Replied, post #81 · Sourcing › Logistics · 31 May 2024 · 0 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…